Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusion during coronary angioplasty: potential mechanisms for free radical generation

• Scheerder, I.K. de
• Kraay, A.M.M. van de
• Koster, J.F.
• Jong, J.W. de
• Serruys, P.W.J.C.
• Lamers, J.M.J.

January 1991
Article

Related Files
View PDF Version (eur_serruys_9071.pdf, 0.5MB)

• Male
• Human
• Adult
• Aged
• Female
• *Angioplasty, Transluminal, Percutaneous Coronary
• Middle Aged
• Myocardium/*metabolism
• 0 (Hypoxanthines)
• *Coronary Vessels
• 68-94-0 (Hypoxanthine)
• Hypoxanthine
• 69-93-2 (Uric Acid)
• Uric Acid/*blood
• 0 (Free Radicals)
• 542-78-9 (Malondialdehyde)
• Angina Pectoris/etiology/*metabolism/therapy
• Arterial Occlusive Diseases/complications/*metabolism/therapy
• Free Radicals
• Hypoxanthines/blood
• Malondialdehyde/*blood
• Myocardial Infarction/metabolism

• malondialdehyde
• radical
• vein-arterial
• production
• hypoxanthine
• baseline
• xanthine oxidase
• urate
• patient
• lipid peroxidation
• difference
• angioplasty
• percutaneous transluminal
• oxygen-free radicals
• transluminal
• lipid
• injury
• xanthine
• study
• peroxidation